Cocrystal Pharma, Inc. — Director's Dealing 2017

Apr 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2017-04-20

Reporting Person: Schinazi Raymond F (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-20	Common Stock	A	4166667	$0.24	Acquired	9044717	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	275520853	Direct

Footnotes

F1: Represents a purchase meeting the requirements of Rule 16b-3.